RHÖN-KLINIKUM AG  / Key word(s): Change in Forecast/Profit Warning

06.11.2012 18:07

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.



RHÖN-KLINIKUM AG

Ad hoc disclosure according to § 15 WpHG

Worsening of group result in the third quarter of 2012 and adjustment of
annual prognosis of RHÖN-KLINIKUM AG

  - Restructuring plan for the University Hospital Giessen and Marburg
    (UKGM) adopted, first time decrease of performance development in the
    third quarter, operative annual result in 2012 probably negatively
    affected by a further amount of EUR 15 million

  - Consensual model describes clear perspective for economically viable
    operation of UKGM

  - Expected operative annual result at group level adjusted by ca. EUR 20
    million

Bad Neustadt a. d. Saale, 6 November 2012

The committees of RHÖN-KLINIKUM AG decided today on the restructuring plan
prepared by a renowned management consultancy with regard to the University
Hospital Giessen and Marburg (UKGM) and its result. The consensus based
approach envisages the immediate implementation of a bundle of measures and
thereby shows a clear perspective for business restoration. Within the
third quarter negative effects on the result of UKGM have occurred that
necessitate an adjustment of the outlook for 2012 and have a negative
impact of around EUR 15 million on the results in the second half of the
year.

A substantial reason for this development is the significant slowing of
growth in the third quarter with regard to in-patient services as well as
revenues at both UKGM sites. In this regard, also a higher than pro-rata
increase of costs for materials and medical supplies as well as the most
recent regulatory and legal changes with effects on expenditures and
accruals for the second half of the year in connection with the preparation
of the accounts negatively affect the result. Besides a relative seasonal
weakness it furthermore becomes clear that the public discussion concerning
the UKGM by different parties now also have a negative effect on the growth
of the UKGM.

At group level, there are furthermore negative effects on the consolidated
results due to increased demand for external consulting services, in
particular for the analysis and planning of immediate measures with regard
to UKGM by an external management consultancy and the financial and
organizational aftermath of the takeover offer by Fresenius as well as
changes in the composition of the Board of Management. These negative one
of effects collectively amount to a mid-range single-figure million amount.

The Board of Management of RHÖN-KLINIKUM AG is optimistic that the
perspective for the UKGM will improve noticeably on the basis of the
analysis that has been performed and the concrete measures that have been
developed and planned in the meantime. Besides the multitude of individual
measures that are proposed in the restructuring concept and target
increasing efficiency and productivity, there is particular focus on the
further development of the medical strategy of the UKGM outside its region.
The analysis has shown a significant market potential in this area that
shall now be utilized in a targeted way. In this regard it will be
necessary to position the UKGM even stronger as a maximum care hospital
also beyond its region and to increase in a targeted way the cooperation
with basic and standard care hospitals. At the same time, the exchange of
knowledge and the positioning of the UKGM within the group network of
RHÖN-KLINIKUM AG shall be developed further so that even more patients at
group level shall be able to participate in the high level of medical care
of university level medical care in Giessen and Marburg.

The effects mentioned above have now materialized in connection with the
preparation of the interim report for the quarter ending 30 September 2012
and make it possible to give a preliminary indication for the result. On
this basis, the group profit for the first nine months will amount to
around EUR 70 million. The Company as of now furthermore expects that the
above mentioned developments that put a burden on the operative result
(EBITDA) will have an effect in the range of ca. EUR 20 million for the
financial year of RHÖN-KLINIKUM AG. Consequently the outlook is adjusted as
follows: RHÖN-KLINIKUM AG expects revenues of EUR 2.85 billion with a
variation of 2.5 per cent for the fiscal year 2012. This revenue target is
supplemented by a prognosis for the EBITDA of EUR 295 million and for the
group profit of EUR 95 million, in each case with a variation of +/- 5 per
cent. The detailed interim report for the quarter ending 30 September 2012
will be published on 8 November 2012.

The Board of Management

Contacts:

RHÖN-KLINIKUM AG
Dr. Kai G. Klinger
Head of Investor Relations
Schlossplatz 1
D-97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 -1318
Fax: +49 9771 99 -1736
E-Mail: kai.klinger@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG
Corporate Communications
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65-1327
Fax: +49 9771 65-1820
Email: kommunikation@rhoen-klinikum-ag.com

RHÖN KLINIKUM AG
Aufsichtsratsvorsitzender: Eugen Münch
Vorstand: Wolfgang Pföhler (Vors.), Volker Feldkamp, Martin Menger,
Jens-Peter Neumann, Dr. Dr. Martin Siebert
Sitz der Gesellschaft: Bad Neustadt a. d. Saale
Registergericht Schweinfurt HRB 1670


06.11.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Phone:        +49 (0)9771 - 65-0
Fax:          +49 (0)9771 - 97 467
E-mail:       rka@rhoen-klinikum-ag.com
Internet:     www.rhoen-klinikum-ag.com
ISIN:         DE0007042301
WKN:          704230
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), München;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
 
End of Announcement                             DGAP News-Service